Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

This funding opportunity, RFA-NS-28-009, is a grant from HHS-NIH11 for research related to Amyotrophic Lateral Sclerosis (ALS). Specifically, it targets an intermediate patient population for expanded access through a U01 Clinical Trial. To win, applicants will need to propose a clinical trial focused on ALS in this specific patient group.